Original Title: 9-Year-Old Scoliosis Child Farewell to Repeated Surgery! “Hong Kong and Macao Medicine and Equipment Communication” First Device Put into Clinical Practice With the help of the “Hong Kong and Macao Medicine and Equipment Link” project, Xiaolei (pseudonym), a 9-year-old patient with severe early-onset scoliosis, became the first beneficiary of the project to introduce the device “magnetic controllable extension titanium rod”. With the help of “magnetic controllable extension titanium rod”, Xiaolei did not have to undergo a total of 10 large wound operations with full spinal exposure every six months, thus avoiding great pain. On May 3, Professor Zhang Wenzhi, Department of Spine Surgery, Shenzhen Hospital,titanium plate gr7, University of Hong Kong, led the operation. With the support of the hospital's operating room, anesthesia, ultrasound,titanium sheet grade 5, radiation and other multidisciplinary teams, Xiaolei successfully performed titanium rod implantation and recovered well after the operation. This is the first application of “magnetic controllable extension titanium rod”, an epoch-making device for early-onset scoliosis in the mainland. Professor Zhang Wenzhi said that compared with traditional growth rods, this device will bring revolutionary progress in the treatment of such diseases. Photo: Professor Zhang Wenzhi, Department of Spine Surgery, Shenzhen Hospital, titanium bar gr7 ,titanium seamless tube, University of Hong Kong Zhang Wenzhi: The traditional growth rod needs an open operation every six months to one year to open the wound and then extend the growth rod. So now the advantage of the “magnetic controllable extension titanium rod” is that there is a very small magnetic motor in the growth rod. We can push this motor through external magnetic instruments, and it will automatically extend, which has the advantage of avoiding open surgery later. Expand the full text According to Xiaolei's mother, at the beginning of this year, when they visited Peking Union Medical College Hospital, they learned that Shenzhen Hospital of Hong Kong University had become the first pilot hospital of “Hong Kong and Macao Medicine and Equipment Link”, and that “Magnetic Controllable Extension Titanium Rod” as the first approved device would soon be put into clinical use. Under the recommendation and docking of the attending professor in Beijing, Xiaolei and his parents embarked on a trip to Shenzhen in April this year, and had an operation on May 3. The operation was very successful. Subsequently, Xiaolei only needs regular follow-up visits every 2-3 months, stretching in vitro through specific instruments, adjusting the length of the titanium rod and the angle of the spine until it is basically cured. On April 29, the patient, Ms. Yang (not her real name), was injected with the first dose of “anti-D immunoglobulin injection”, becoming the first patient to benefit from the “Hong Kong-Macao Pharmaceutical Equipment Communication” project. On May 3, Xiaolei, a child, also underwent a successful operation, becoming the beneficiary of the first imported instrument “magnetic controllable extension titanium rod”. Photo: Lu Chongmao, Dean of Shenzhen Hospital, University of Hong Kong Lu Chongmao: “The listing of medical devices must be approved by the state. Different products have different time. Generally speaking, many medical devices in the mainland are three to five years later than those in Hong Kong,titanium sheet grade 5, and some are even longer. So through the policy of” Hong Kong and Macao Medical Devices Link “, we can speed up the medical use of more advanced medical devices in Shenzhen and even the whole Greater Bay Area, and also provide data to the state to speed up the approval of listing.” END Source | Happy 1062 Reporter | Mai Jie Editor | Qiu Xiang returns to Sohu to see more Responsible Editor:. yunchtitanium.com
